RESMED INC — Director's Dealing 2014

Jun 5, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2014-06-03

Reporting Person: PENDARVIS DAVID (Chief Administrative Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-03	ResMed Common Stock	M	5000	$15.520	Acquired	74207.141	Direct
2014-06-03	ResMed Common Stock	S	5000	$49.760	Disposed	69207.141	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-03	ResMed Stock Options	$15.52	M	5000	Disposed	2015-11-20	ResMed Common Stock (5000)	Direct

Footnotes

F1: The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.

F2: Represents date options first became exercisable. Options vest 1/4 annually on the anniversary of the grant.

F3: This transaction was executed in multiple trades at prices ranging from $49.45 and $49.96. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.